The Board proposes the development of rule amendments to address disciplinary guidelines for engaging in a pattern of practice when prescribing medicinal drugs or controlled substances that demonstrates a lack of reasonable skill and safety to patients; failure to consult the prescription drug monitoring system; and failure to report adverse incidents in planned out-of-hospital births; provisions for a notice of non-compliance to be issued for failure to submit required documentation as required by Section 386.986(4)(b), F.S.; and citation penalties for failure to submit required documentation as required by Section 386.986(4)(b), F.S.; failure to consult the prescription drug monitoring system; and failure to report adverse incidents in planned out-of-hospital births.